John Lin, MD, MSHP

Peer-Reviewed Articles

1. Thomas, Z, Johns, AC, Glover, M, Crupi, E, Nieto, Y, Ward, JF, Karam, JA, Hofstetter, WL, Desai, M, Choi, S, Shah, AY, Lin, JK, Moussa, MJ, Jiang, CY, Alhalabi, O, Campbell, M. Divergent biology and outcomes of somatic transformations in germ cell tumors. Oncologist 31(8), 2026. e-Pub 2026. PMID: 42378441.
2. Shih YT, Xu XL, Liu L, Lin JK. Comparison of Health Care Cost Trajectories in the Last Year of Life by Age at Death. JAMA Netw Open 9(6):e2616623, 2026. e-Pub 2026. PMID: 42241003.
3. Lin JK, Xiang JJ, Lei X, Desai S, Trish E, Chino F, Li M, Giordano SH, Xu Y, Jiang C, Doshi JA, Shih YT. Identifying Meaningful Patient Savings on Generics: Direct-to-Consumer Prices Versus Commercial Insurance Cost Sharing. Ann Intern Med, 2026. e-Pub 2026. PMID: 42184421.
4. Li P, Klebanoff MJ, Lin JK, Doshi KD, Chahin S, Doshi JA. Medicare Part D Formulary Coverage of Disease-Modifying Therapies for Multiple Sclerosis. JAMA Health Forum 7(4), 2026. e-Pub 2026. PMID: 42030055.
5. Shaw L, Gao J, Lin JK, Goswami S, Msaouel P, Guo CC, Tannir NM, Siefker-Radtke AO, Alhalabi O, Campbell MT. Efficacy of Immune Checkpoint Blockade in Advanced Upper Tract Urothelial Cancer With DNA Mismatch Repair Deficiency or Microsatellite Instability. JCO Precis Oncol 10, 2026. e-Pub 2026. PMID: 41911516.
6. Lin JK, Li P, Lei X, Desai SM, Doshi JA. Specialty Oral Anticancer Prescription Fill Rates After Medicare Part D Cost-Sharing Changes in 2024. JAMA:e2522134, 2025. e-Pub 2025. PMID: 41460645.
7. Li P, Lin JK, Klebanoff MJ, Palkar R, Chahin S, Doshi JA. Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis. Neurol Clin Pract 15(6):200536, 2025. e-Pub 2025. PMID: 40969461.
8. Hahn A, Chahoud J, Skelton W, Yuan Y, Zurita-Saavedra A, Kovitz C, Alhalabi O, Campbell M, Jonasch E, Lin J, Desai M, Santos M, Hwang H, Corn P, Msaouel P, Tannir N. A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo). Ann Oncol 36(11), 2025. e-Pub 2025. PMID: 41115467.
9. Lin JK, Xu Y, Xiang JJ, Singhi EK, Jiang C, Chavez-MacGregor M, Shih YT. Nationwide Response to Carboplatin and Cisplatin Shortages in Lung Cancer. JAMA Oncology 11(12):1538-1540, 2025. e-Pub 2025. PMID: 41037288.
10. Canavan ME, Cheng L, Xiang JJ, Lin JK, Hui D, Zhao H, Nortje N, Ratan R, Cherny N, Pham T, Giordano SH, Niu J, Adelson KB. Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality. Journal of Clinical Oncology 43(31):3391-3402, 2025. e-Pub 2025. PMID: 41004691.
11. Lin JK, Niu J, Giordano SH, Li P, Snyder RA, Liao K, Li M, Aparicio A, Chapin W, Zhang J, Xiang J, Perera N, Pain D, Guerra CE, Doshi JA. Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate Cancers. Journal of Clinical Oncology 43(30):3254-3265, 2025. e-Pub 2025. PMID: 40865035.
12. Nieto Y, Ward JF, Hofstetter W, Rice D, Karam JA, Pisters L, Vauthey JN, Shah A, Lin JK, Johns AC, Araujo J, Tu SM, Wang J, Li J, Abudayyeh A, Thall PF, Bassett R, Barnett M, Gulbis A, Shigle TL, Ramdial J, Popat U, Qazilbash M, Jones RB, Andersson BS, Shpall EJ, Sheikh I, Pagliaro L, Campbell MT. High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors. Clin Cancer Res 32(2):300-311, 2025. e-Pub 2025. PMID: 40853903.
13. Herb J, Liao KP, Lin JK, Lewis KA, Giordano SH, Katz MHG, Snyder RA. Racial and Ethnic Disparities in Receipt of Guideline-Concordant Pancreatic Cancer Care Among Older Adults in the United States. JCO Oncol Pract 22(6):1075-1086, 2025. e-Pub 2025. PMID: 40768681.
14. Doshi JA, Li P, Klebanoff MJ, Lin JK. Inflation Reduction Act Provisions and Medicare Part D Out-of-Pocket Costs for Specialty Drugs. JAMA Health Forum 6(5), 2025. e-Pub 2025. PMID: 40377932.
15. Doshi JA, Li P, Asthana S, Lin JK. Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan. JCO Oncol Pract, 2025. e-Pub 2025. PMID: 40279533.
16. Xiang JJ, Campbell MT, Tu SM, Araujo J, Nieto Y, Lin JK, Xiao L, Shah AY, Wang J. Doxorubicin, Paclitaxel, and Cisplatin (ATP) for Relapsed/Refractory Germ Cell Tumors. Clin Genitourin Cancer 22(6):102242, 2024. e-Pub 2024. PMID: 39532049.
17. Lin JK, Hearn CM, Getzen E, Long Q, Lee DC, Keaveny TM, Jayadevappa R, Robinson KW, Wong YN, Maxwell KN, Narayan V, Haas NB, Takvorian SU, Bikle DD, Chiang JM, Khan AN, Rajapakse CS, Morgans AK, Parikh RB. Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer. Eur Urol Oncol 7(4):794-803, 2024. e-Pub 2024. PMID: 37926618.
18. Klebanoff MJ, Li P, Lin JK, Doshi JA. Formulary Coverage of Brand-Name Adalimumab and Biosimilars Across Medicare Part D Plans. JAMA 332(1):74-76, 2024. e-Pub 2024. PMID: 38842823.
19. Shung DL, Lin JK, Laine L. Achieving Value by Risk Stratification With Machine Learning Model or Clinical Risk Score in Acute Upper Gastrointestinal Bleeding: A Cost Minimization Analysis. Am J Gastroenterol 119(2):371-373, 2024. e-Pub 2024. PMID: 37753930.
20. Sinharoy A, Reddy N, Lin JK, Nambi V, Yang EY, Kougias P, Taylor AA, Lumsden AB, Ballantyne CM, Brunner G. Longitudinal Magnetic Resonance Imaging-Based Superficial Femoral Artery Velocity Measurements in Diabetic and Nondiabetic Patients With Peripheral Artery Disease. Top Magn Reson Imaging 32(6):57-65, 2023. e-Pub 2023. PMID: 38051028.
21. Sinharoy A, Reddy N, Lin JK, Nambi V, Yang EY, Kougias P, Taylor AA, Lumsden AB, Ballantyne CM, Morrisett JD, Brunner G. Magnetic resonance imaging based superficial femoral artery velocity measurements in peripheral artery disease. Magn Reson Imaging 93:128-134, 2022. e-Pub 2022. PMID: 35940380.
22. Lin JK, Jacobs LA, Blauch A, Shulman LN, Vaughn DJ. Guideline discordant care in patients with metastatic germ cell tumors. Urol Oncol 40(8):385.e9-385.e17, 2022. e-Pub 2022. PMID: 35659482.
23. Lin JK, Li P, Doshi JA, Desai SM. Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics. JAMA Health Forum 3(6):e221435, 2022. e-Pub 2022. PMID: 35977245.
24. Sandhu AT, Heidenreich PA, Lin JK, Parizo J, Bhattacharya J, Goldhaber-Fiebert JD. Perks and Pitfalls of Performance-Linked Reimbursement for Novel Drugs: The Case of Sacubitril-Valsartan. Circ Cardiovasc Qual Outcomes 15(1):e007993, 2022. e-Pub 2022. PMID: 35041480.
25. Barnes JI, Lin JK, Gupta D, Owens DK, Goldhaber-Fiebert JD, Kunz PL. Cost-Effectiveness of Initial Versus Delayed Lanreotide for Treatment of Metastatic Enteropancreatic Neuroendocrine Tumors. J Natl Compr Canc Netw 18(9):1200-1209, 2020. e-Pub 2020. PMID: 32886901.
26. Lin JK, Hong J, Phibbs C, Almenoff P, Wagner T. Evaluating the Role of Past Clinical Information on Risk Adjustment. Medical Care 58(2):169-173, 2020. e-Pub 2020. PMID: 31688567.
27. Bentham J, Singh GM, Danaei G, Green R, Lin JK, Stevens GA, Farzadfar F, Bennett JE, Cesare MD, Dangour AD, Ezzati M. Multi-dimensional characterisation of global food supply from 1961-2013. Nat Food 1(1):70-75, 2020. e-Pub 2020. PMID: 32002520.
28. Lin JK, Moran AE, Bibbins-Domingo K, Falase B, Pedroza Tobias A, Mandke CN, Kazi DS. Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study. Lancet Global Health 7(10):e1346-e1358, 2019. e-Pub 2019. PMID: 31477544.
29. Lin JK, Muffly LS, Spinner MA, Barnes JI, Owens DK, Goldhaber-Fiebert JD. Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma. Journal of Clinical Oncology 37(24):2105-2119, 2019. e-Pub 2019. PMID: 31157579.
30. Lin JK, Lerman BJ, Barnes JI, Boursiquot BC, Tan YJ, Robinson AQL, Davis KL, Owens DK, Goldhaber-Fiebert JD. Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 36(32):3192-3202, 2018. e-Pub 2018. PMID: 30212291.
31. Raffel KE, Beach LY, Lin JK, Berchuck JE, Abram S, Markle E, Patel S. Naloxone Distribution and Training for Patients with High-Risk Opioid Use in a Veterans Affairs Community-Based Primary Care Clinic. Perm J 22, 2018. e-Pub 2018. PMID: 29616917.
32. Lin JK, Chow DS, Sheu L, Rehani B. Wernicke-Like Encephalopathy Associated With Ifosfamide. Neurohospitalist 7(1):49-50, 2017. e-Pub 2017. PMID: 28042371.
33. (NCD-RisC) NCD. Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants. Lancet Diabetes Endocrinol 3(8):624-37, 2015. e-Pub 2015. PMID: 26109024.
34. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2(8):634-47, 2014. e-Pub 2014. PMID: 24842598.
35. Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, Farzadfar F, Stevens GA, Riley LM, Lu Y, Rao M, Ezzati M. Response to letter regarding article, "the global cardiovascular risk transition: associations of four metabolic risk factors with macroeconomic variables in 1980 and 2008". Circulation 128(18):e378, 2013. e-Pub 2013. PMID: 24166421.
36. Murray CJ, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D, Dellavalle R, Danaei G, Ezzati M, Fahimi A, Flaxman D, Foreman, Gabriel S, Gakidou E, Kassebaum N, Khatibzadeh S, Lim S, Lipshultz SE, London S, Lopez, MacIntyre MF, Mokdad AH, Moran A, Moran AE, Mozaffarian D, Murphy T, Naghavi M, Pope C, Roberts T, Salomon J, Schwebel DC, Shahraz S, Sleet DA, Murray, Abraham J, Ali MK, Atkinson C, Bartels DH, Bhalla K, Birbeck G, Burstein R, Chen H, Criqui MH, Dahodwala, Jarlais, Ding EL, Dorsey ER, Ebel BE, Ezzati M, Fahami, Flaxman S, Flaxman AD, Gonzalez-Medina D, Grant B, Hagan H, Hoffman H, Kassebaum N, Khatibzadeh S, Leasher JL, Lin JK, Lipshultz SE, Lozano R, Lu Y, Mallinger L, McDermott MM, Micha R, Miller TR, Mokdad AA, Mokdad AH, Mozaffarian D, Naghavi M, Narayan KM, Omer SB, Pelizzari PM, Phillips D, Ranganathan D, Rivara FP, Roberts T, Sampson U, Sanman E, Sapkota A, Schwebel DC, Sharaz S, Shivakoti R, Singh GM, Singh D, Tavakkoli M, Towbin JA, Wilkinson JD, Zabetian A, Murray, Abraham J, Ali MK, Alvardo M, Atkinson C, Baddour LM, Benjamin EJ, Bhalla K, Birbeck G, Bolliger I, Burstein R, Carnahan E, Chou D, Chugh SS, Cohen A, Colson KE, Cooper LT, Couser W, Criqui MH, Dabhadkar KC, Dellavalle RP, Jarlais, Dicker D, Dorsey ER, Duber H, Ebel BE, Engell RE, Ezzati M, Felson DT, Finucane MM, Flaxman S, Flaxman AD, Fleming T, Foreman, Freedman G, Freeman MK, Gakidou E, Gillum RF, Gonzalez-Medina D, Gosselin R, Gutierrez HR, Hagan H, Havmoeller R, Hoffman H, Jacobsen KH, James SL, Jasrasaria R, Jayarman S, Johns N, Kassebaum N, Khatibzadeh S, Lan Q, Leasher JL, Lim S, Lipshultz SE, London S, Lopez, Lozano R, Lu Y, Mallinger L, Meltzer M, Mensah GA, Michaud C, Miller TR, Mock C, Moffitt TE, Mokdad AA, Mokdad AH, Moran A, Naghavi M, Narayan KM, Nelson RG, Olives C, Omer SB, Ortblad K, Ostro B, Pelizzari PM, Phillips D, Raju M, Razavi H, Ritz B, Roberts T, Sacco RL, Salomon J, Sampson U, Schwebel DC, Shahraz S, Shibuya K, Silberberg D, Sing. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 310(6):591-608, 2013. e-Pub 2013. PMID: 23842577.
37. Danaei G, Singh GM, Paciorek CJ, Lin JK, Cowan MJ, Finucane MM, Farzadfar F, Stevens GA, Riley LM, Lu Y, Rao M, Ezzati M, Collaborating Group GBOMRFOCD. The global cardiovascular risk transition: associations of four metabolic risk factors with national income, urbanization, and Western diet in 1980 and 2008. Circulation 127(14):1493-502, 1502e1-8, 2013. e-Pub 2013. PMID: 23481623.
38. Lim, Vos T, Murray CJ, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gonzalez-Medina D, Gosselin R, Grainger R, Grant B, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Lin JK, Knowlton LM, Kobusingye O, Koranteng A. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2197-223, 2012. e-Pub 2012. PMID: 23245608.
39. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng AT, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S, Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L, Marks R, Martin R, McGale P, McGrath J, Mehta S, Mensah GA, Merriman TR, Micha R, Michaud C, Mishra V, Mohd Hanafiah K, Mokdad AA, Morawska L, Mozaffarian D, Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R, Olives C, Omer SB, Orchard J, Osborne R, Ostro B, Page A, Pandey KD, Parry CD, Passmore E, Patra J, Pearce N, Pelizzari PM, Petzold M, Phillips MR, Pope D, Pope CA, Powles J, Rao M, Razavi H, Rehfuess EA, Rehm JT, Ritz B, Rivara FP, Roberts T, Robinson C, Rodriguez-Portales JA, Romieu I, Room R, Rosenfeld LC, Roy A, Rushton L, Salomon JA, Sampson U, Sanchez-Riera L, Sanman E, Sapkota A, Seedat S, Shi P, Shield K, Shivakoti R, Singh GM, Sleet DA, Smith E, Smith KR, Stapelberg NJ, Steenland K, Stöckl H, Stovner LJ, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2224-60, 2012. e-Pub 2012. PMID: 23245609.
40. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Bin Abdulhak A, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Ali SE, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gosselin R, Grainger R, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo JP, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lalloo R, Lin, JK. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380(9859):2163-96, 2012. e-Pub 2012. PMID: 23245607.
41. Singh GM, Danaei G, Pelizzari PM, Lin JK, Cowan MJ, Stevens GA, Farzadfar F, Khang YH, Lu Y, Riley LM, Lim SS, Ezzati M. The age associations of blood pressure, cholesterol, and glucose: analysis of health examination surveys from international populations. Circulation 125(18):2204-2211, 2012. e-Pub 2012. PMID: 22492580.
42. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 378(9785):31-40, 2011. e-Pub 2011. PMID: 21705069.
43. Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ, Farzadfar F, Stevens GA, Lim SS, Riley LM, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Pressure). National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet 377(9765):568-77, 2011. e-Pub 2011. PMID: 21295844.
44. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet 377(9765):557-67, 2011. e-Pub 2011. PMID: 21295846.
45. Farzadfar F, Finucane MM, Danaei G, Pelizzari PM, Cowan MJ, Paciorek CJ, Singh GM, Lin JK, Stevens GA, Riley LM, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Cholesterol). National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants. Lancet 377(9765):578-86, 2011. e-Pub 2011. PMID: 21295847.

Review Articles

1. Lin JK, Parikh RB. Bone Health in Prostate Cancer Survivors: Recent Lessons and Opportunities for Improvement. Eur Urol Focus 9(3):422-424, 2023. e-Pub 2023. PMID: 37117113.
2. Graham LS, Lin JK, Lage DE, Kessler ER, Parikh RB, Morgans AK. Management of Prostate Cancer in Older Adults. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 43:e390396, 2023. e-Pub 2023. PMID: 37207299.
3. Lin JK, Lin E, Nemunaitis J. Bacteria in the treatment of cancer. Curr Opin Mol Ther 6(6):629-39, 2004. e-Pub 2004. PMID: 15663328.

Other Articles

1. Lai JH, Avancena ALV, Lin JK, Wanis KN Initiation of Gabapentin with Opioids and Risk of Respiratory Cardiovascular and Opioid-Related Adverse Events Following Surgery for Breast Cancer, 2026. PMID: 42629504.
2. Hu, X, Yang, H, Lin, JK Narrow Networks and Coverage Changes Among Medicare Advantage Beneficiaries With Cancer. JAMA Network Open 9(6), 2026. PMID: 42301716.

Editorials

1. Hu X, Yang H, Lin JK. Narrow Networks and Coverage Changes Among Medicare Advantage Beneficiaries With Cancer. JAMA Netw Open 9(6), 2026. PMID: 42301715.
2. Bange EM, Lin JK. Time Toxicity of Clinical Trials-Better Than Feared. JAMA Netw Open 8(4), 2025. PMID: 40232726.
3. Lin JK, Barnes JI, Doshi JA, Ghabri S, Kolominsky-Rabas P, O’Rourke B. The Medicare Drug Price Negotiation Program: Arriving at a Fair Price - Considerations from Other Countries. Health Affairs Forefront, 2023.
4. Lin JK, Barnes JI, Doshi JA. The Medicare Drug Price Negotiation Program: Considerations For Therapeutic Alternatives. Health Affairs Forefront, 2023.

Letters to the Editor

1. GBD 2010 Country Collaboration. GBD 2010 country results: a global public good. Lancet 381: 965-70, 2013.